New guidelines for topical NSAIDs in the osteoarthritis treatment paradigm

Current Medical Research and Opinion

Volumn 26, Issue 12, 2010, Pages 2871-2876

  Altman, Roy D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Guidelines; Hand osteoarthritis; Knee osteoarthritis; Nonsteroidal anti inflammatory drugs; Topical administration

Indexed keywords

CALCITONIN; CAPSAICIN; CHONDROITIN SULFATE; DICLOFENAC; GLUCOSAMINE; HYALURONIC ACID; LIDOCAINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; PROSTAGLANDIN SYNTHASE INHIBITOR; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRAMADOL;

APPLICATION SITE REACTION; DIGESTIVE SYSTEM PERFORATION; DIGESTIVE SYSTEM ULCER; DRUG EFFICACY; DRUG EXPOSURE; DRUG SAFETY; EUROPE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HAND OSTEOARTHRITIS; HIGH RISK PATIENT; HUMAN; KNEE OSTEOARTHRITIS; OSTEOARTHRITIS; PRACTICE GUIDELINE; REVIEW; TREATMENT INDICATION; UNITED STATES;

ADMINISTRATION, TOPICAL; ADULT; ALGORITHMS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; HUMANS; MALE; OSTEOARTHRITIS; PRACTICE GUIDELINES AS TOPIC;

EID: 78349293731     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2010.533650     Document Type: Review

References (32)

1. Lawrence RC, Felson DT, Helmick CG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 2008;58:26-35
2. Lopez AD, Mathers CD, Ezzati M, et al. Global Burden of Disease and Risk Factors. New York, NY: Oxford University Press, 2006
3. McKenna MT, Michaud CM, Murray CJ, et al. Assessing the burden of disease in the United States using disability-adjusted life years. Am J Prev Med 2005; 28:415-23
4. Salaffi F, Carotti M, Stancati A, et al. Health-related quality of life in older adults with symptomatic hip and knee osteoarthritis: a comparison with matched healthy controls. Aging Clin Exp Res 2005;17:255-63
5. Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum 1986;29:1039-49
6. Felson DT. Developments in the clinical understanding of osteoarthritis. Arthritis Res Ther 2009;11:203
7. Toivanen AT, Heliovaara M, Impivaara O, et al. Obesity, physically demanding work and traumatic knee injury are major risk factors for knee osteoarthritis - a population-based study with a follow-up of 22 years. Rheumatology 2010;49:308-14
8. Grotle M, Hagen KB, Natvig B, et al. Prevalence and burden of osteoarthritis: results from a population survey in Norway. J Rheumatol 2008;35:677-84
9. Blagojevic M, Jinks C, Jeffery A, et al. Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis. Osteoarthritis Cartilage 2010;18:24-33
10. Srikanth VK, Fryer JL, Zhai G, et al. A meta-analysis of sex differences prevalence, incidence and severity of osteoarthritis. Osteoarthritis Cartilage 2005;13:769-81
11. Kalichman L, Li L, Batsevich V, et al. Prevalence, pattern and determinants of radiographic hand osteoarthritis in five Russian community-based samples. Osteoarthritis Cartilage 2010;18:803-9
12. Sharma L, Song J, Dunlop D, et al. Varus and valgus alignment and incident and progressive knee osteoarthritis. Ann Rheum Dis 2010;69:1940-5
13. Kadam UT, Jordan K, Croft PR. Clinical comorbidity in patients with osteoar-thritis: a case-control study of general practice consulters in England and Wales. Ann Rheum Dis 2004;63:408-14
14. Chan KW, Ngai HY, Ip KK, et al. Co-morbidities of patients with knee osteo-arthritis. Hong Kong Med J 2009;15:168-72
15. Puenpatom RA, Victor TW. Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data. Postgrad Med 2009;121:9-20
16. Evans JM, McMahon AD, McGilchrist MM, et al. Topical non-steroidal anti-inflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: a record linkage case-control study. BMJ 1995;311:22-6
17. Garcia Rodriguez LA, Hernandez-Diaz S. Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs. Epidemiology 2001;12:570-6
18. Motsko SP, Rascati KL, Busti AJ, et al. Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk. Drug Saf 2006;29:621-32
19. Evans JM, McGregor E, McMahon AD, et al. Non-steroidal anti-inflammatory drugs and hospitalization for acute renal failure. QJM 1995;88:551-7
20. Kienzler J, Gold M, Nollevaux F. Systemic bioavailability of topical diclofenac sodium gel 1% versus oral diclofenac sodium in healthy volunteers. J Clin Pharmacol New Drugs 2010;50:50-61
21. Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008;16:137-62
22. Jordan KM, Arden NK, Doherty M, et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003;62:1145-55
23. Zhang W, Doherty M, Leeb BF, et al. EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007;66:377-88
24. American Academy of Orthopaedic Surgeons. Treatment of Osteoarthritis of the Knee (Non-Arthroplasty). Rosemont, IL: American Academy of Orthopaedic Surgeons 2008
25. National Collaborating Centre for Chronic Conditions. Osteoarthritis: The Care and Management of Osteoarthritis in Adults. London, UK: Royal College of Physicians, 2008
26. American Geriatrics Society. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc 2009;57:1331-46
27. Antman EM, Bennett JS, Daugherty A, et al. Use of nonsteroidal antiinflam-matory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation 2007;115:1634-42
28. American College of Rheumatology. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 2000;43:1905-15
29. Zhang W, Nuki G, Moskowitz RW, et al. OARSI recommendations for the management of hip and knee osteoarthritis Part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage 2010;18:476-99
30. Altman RD, Dreiser RL, Fisher CL, et al. Diclofenac sodium gel in patients with primary hand osteoarthritis: a randomized, double-blind, placebo-controlled trial. J Rheumatol 2009;36:1991-9
31. Barthel HR, Haselwood D, Longley S, et al. Diclofenac sodium topical gel 1% in patients with primary knee osteoarthritis: a randomized, double-blind, placebo-controlled trial. Semin Arthritis Rheum 2009;39:203-12
32. Simon LS, Grierson LM, Naseer Z, et al. Efficacy and safety of topical diclo-fenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritis. Pain 2009;143:238-45